Erin Paterson

641 total citations · 1 hit paper
23 papers, 450 citations indexed

About

Erin Paterson is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Erin Paterson has authored 23 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Oncology. Recurrent topics in Erin Paterson's work include Vascular Malformations and Hemangiomas (4 papers), Cancer Cells and Metastasis (4 papers) and Pluripotent Stem Cells Research (3 papers). Erin Paterson is often cited by papers focused on Vascular Malformations and Hemangiomas (4 papers), Cancer Cells and Metastasis (4 papers) and Pluripotent Stem Cells Research (3 papers). Erin Paterson collaborates with scholars based in New Zealand, Australia and United Kingdom. Erin Paterson's co-authors include Swee T. Tan, Clint Gray, Lifeng Peng, Madeleine P. J. White, Tonia L. Vincent, Fiona E. Watt, A. C. P. Campbell, J. K. Steward, Paul F. Davis and R H Withrington and has published in prestigious journals such as British Journal of Cancer, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.

In The Last Decade

Erin Paterson

23 papers receiving 429 citations

Hit Papers

Unlocking hidden potential: advancements, approaches, and... 2023 2026 2024 2025 2023 25 50 75

Peers

Erin Paterson
Jessica McHugh United States
Debbie Roeleveld Netherlands
J. Camilleri United Kingdom
Erin Paterson
Citations per year, relative to Erin Paterson Erin Paterson (= 1×) peers Hiroyuki Hounoki

Countries citing papers authored by Erin Paterson

Since Specialization
Citations

This map shows the geographic impact of Erin Paterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Paterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Paterson more than expected).

Fields of papers citing papers by Erin Paterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Paterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Paterson. The network helps show where Erin Paterson may publish in the future.

Co-authorship network of co-authors of Erin Paterson

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Paterson. A scholar is included among the top collaborators of Erin Paterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Paterson. Erin Paterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paterson, Erin, et al.. (2023). Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy. British Journal of Cancer. 130(5). 703–715. 95 indexed citations breakdown →
2.
Peng, Lifeng, et al.. (2022). Utility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications. Cells. 12(1). 153–153. 8 indexed citations
3.
Brasch, Helen D., Nicholas Bockett, Erin Paterson, et al.. (2021). Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma. Life. 11(10). 1106–1106. 6 indexed citations
4.
Brasch, Helen D., Nicholas Bockett, Erin Paterson, et al.. (2021). Cancer Stem Cells in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System. Cells. 10(2). 243–243. 14 indexed citations
5.
Brasch, Helen D., et al.. (2021). Expression of Cathepsins B, D, and G in Extracranial Arterio-Venous Malformation. Frontiers in Surgery. 8. 676871–676871. 2 indexed citations
6.
Bockett, Nicholas, et al.. (2021). Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma. Frontiers in Oncology. 11. 690460–690460. 5 indexed citations
7.
Garriga, César, Erin Paterson, Jennifer Alderson, et al.. (2021). Clinical and molecular associations with outcomes at 2 years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK). The Lancet Rheumatology. 3(9). e648–e658. 21 indexed citations
8.
Brasch, Helen D., et al.. (2021). Expression of Cathepsins B, D, and G in Hypertrophic Port-wine Stain. 2(3). e022–e022. 1 indexed citations
9.
Brasch, Helen D., et al.. (2021). Stemness-Associated Markers Are Expressed in Extracranial Arteriovenous Malformation. Frontiers in Surgery. 8. 621089–621089. 5 indexed citations
10.
Bockett, Nicholas, et al.. (2021). Expression of cathepsins B and D by cancer stem cells in head and neck metastatic malignant melanoma. Melanoma Research. 31(5). 426–438. 6 indexed citations
11.
Brasch, Helen D., et al.. (2020). Cancer Stem Cells in Head and Neck Metastatic Malignant Melanoma Express Components of the Renin-Angiotensin System. Life. 10(11). 268–268. 15 indexed citations
12.
Garriga, César, K.M. Leyland, Erin Paterson, et al.. (2020). Predictive factors for patient reported symptoms and radiographic structural change at 2 years after acute knee injury. Osteoarthritis and Cartilage. 28. S322–S323. 2 indexed citations
13.
Schaijik, Bede van, Nicholas Bockett, Helen D. Brasch, et al.. (2020). Cancer Stem Cell Subpopulations Are Present Within Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma. Frontiers in Oncology. 10. 1091–1091. 13 indexed citations
14.
Schaijik, Bede van, Nicholas Bockett, Helen D. Brasch, et al.. (2020). Identification of Cancer Stem Cell Subpopulations in Head and Neck Metastatic Malignant Melanoma. Cells. 9(2). 324–324. 21 indexed citations
15.
Gardner, Laura, Erin Paterson, Andrew Freidin, et al.. (2016). Variation in a single nucleotide polymorphism in the 5'UTR of growth and differentiation factor-5 (GDF-5) predicts clinical outcome at 3 months following acute knee joint injury. Osteoarthritis and Cartilage. 24. S40–S41. 1 indexed citations
16.
Watt, Fiona E., Erin Paterson, Andrew Freidin, et al.. (2016). Acute Molecular Changes in Synovial Fluid Following Human Knee Injury: Association With Early Clinical Outcomes. Arthritis & Rheumatology. 68(9). 2129–2140. 71 indexed citations
17.
Vincent, Tonia L., Anastasios Chanalaris, Samuel J. Bullers, et al.. (2014). IL18 is secreted upon joint injury and is a key pathogenic cytokine in murine osteoarthritis. Osteoarthritis and Cartilage. 22. S131–S132. 1 indexed citations
18.
Pathan, Ejaz, Sonya Abraham, R H Withrington, et al.. (2012). Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. Annals of the Rheumatic Diseases. 72(9). 1475–1480. 98 indexed citations
19.
Edwards, J. E. Hocking, et al.. (1996). Pre- and post-natal wool follicle development and density in sheep of five genotypes. The Journal of Agricultural Science. 126(3). 363–370. 9 indexed citations
20.
Paterson, Erin, et al.. (1994). Prenatal wool follicle development in Romney, Merino and Merino- Romney cross sheep. Proceedings of the New Zealand Society of Animal Production. 54. 131–134. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026